Varsinais-Suomen hyvinvointialue — Sponsor Intelligence | 9 EU Trials

Filter these 9 trials by condition, phase, country and more.

9 Registered trials

1 Recruiting

4 Completed trials

1 Countries active

7 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase I

Phase I (Other)

100%

4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

Top indications

9 total

Dosimetry, kinetics and test-retest properties of a novel norepinephrine transporter radiotracer [18F]NS12137 Pending

2024-517531-40-00 Phase I 1 country
Neonatal Brain Ultrasound With CEUS and Elastography Pending

2024-519611-33-00 Phase IV 1 country SULFUR HEXAFLUORIDE
Fecal microbiota transplantation in patients receiving infliximab and vedolizumab for ulcerative colitis: A randomized controlled trial Pending

2024-520373-12-00 Phase IV 1 country INFLIXIMAB; VEDOLIZUMAB
Hydroxychloroquine in progressive MS Pending

2025-522573-11-00 Phase II 1 country HYDROXYCHLOROQUINE SULFATE
Clinical use of USPIO contrast media in the assessment of pelvic lymph node metastasis in rectal cancer. Recruiting

2024-514831-34-00 Phase III 1 country
The effect of losartan on cephalexin Ended

2025-525059-23-00 Phase I (Other) 1 country
Effect of cladribine treatment on microglial activation in the CNS Ended

2024-519921-39-00 Phase IV 1 country CLADRIBINE
Maternal pertussis immunization in Finland, 4 years (MIFI-4Y) Ended

2024-510787-23-00 Phase IV 1 country POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGL…
dTap booster vaccination of health care workers (HC dTap) Ended

2024-511478-56-00 Phase IV 1 country DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMA…

Showing 1–9 of 9 trials